LION: improving drug discovery
LION bioscience this week launched the latest version of its open integration platform, LION DiscoveryCenter 3.2, with an enhanced chemistry functionality for integrated drug discovery.
LION bioscience this week launched the latest version of its open integration platform, LION DiscoveryCenter 3.2, with an enhanced chemistry functionality for integrated drug discovery.
An expert group on intellectual property rights (IPRs) has warned that rules governing the protection of copyrights, database rights and patents hamper scientific endeavour and must be changed 'in the interest of society', reports the European...
US provider of drug discovery tools Deltagen saw cutbacks in workforce and the closure of operating units help boost revenue by 93 per cent for the fourth quarter of 2002 to $4.7 million (€4.3m), compared to $2.5 million (€2.3m) for the same period in...
Millipore, which specialises in providing technologies, tools and services for the discovery, development and production of new therapeutic drugs, has reported first-quarter 2003 sales of $187 million (€173 million), up 13 per cent from the same...
Total revenues for the four emerging sectors of protein array, crucial antibody array, peptide biochip, protein biochip, and solution bead/particle array were estimated at $90 million (€83million) in 2002, writes market analyst Business Communications...